Aigen Investment Management, LP Iovance Biotherapeutics, Inc. Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $140,490 - $323,369	18,510 New	18,510 $274,000
Q1 2022 May 05, 2022	SELL	$12.38 - $19.1 $222,790 - $343,723	-17,996 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $297,833 - $497,229	17,996 New	17,996 $333,000
Q3 2020 Nov 06, 2020	SELL	$27.75 - $36.3 $294,372 - $385,070	-10,608 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$27.21 - $41.0 $288,643 - $434,928	10,608 New	10,608 $291,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.